A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

Genetic alterations in PI3K (phosphoinositide 3-kinase) signalling are common in cancer and include deletions in PTEN (phosphatase and tensin homologue deleted on chromosome 10), amplifications of PIK3CA and mutations in two distinct regions of the PIK3CA gene. This suggests drugs targeting PI3K, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamieson, Stephen, Flanagan, Jack U., Kolekar, Sharada, Buchanan, Christina, Kendall, Jackie D., Lee, Woo-Jeong, Rewcastle, Gordon W., Denny, William A., Singh, Ripudaman, Dickson, James, Baguley, Bruce C., Shepherd, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174055/
https://www.ncbi.nlm.nih.gov/pubmed/21668414
http://dx.doi.org/10.1042/BJ20110502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174055/
https://www.ncbi.nlm.nih.gov/pubmed/21668414
http://dx.doi.org/10.1042/BJ20110502

Ejemplares similares